Erratum: Chronic Granulomatous Disease: A 25-Year Patient Registry Based on a Multistep Diagnostic Procedure, from the Referral Center for Primary Immunodeficiencies in Greece [J Clin Immunol, 33, (2013) 1302-1309, DOI 10.1007/s10875-013-9940-z];Chronic granulomatous disease: A 25-year patient registry based on a multistep diagnostic procedure, from the referral center for primary immunodeficiencies in Greece

Journal of Clinical Immunology

Volumn 33, Issue 8, 2013, Pages 1302-1309

  Raptaki, Maria ^a   Varela, Ioanna ^a   Spanou, Kleopatra ^a   Tzanoudaki, Marianna ^a   Tantou, Sofia ^a   Liatsis, Manolis ^a   Constantinidou, Nikki ^a   Bakoula, Chryssa ^b   Roos, Dirk ^c   Kanariou, Maria ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Chronic granulomatous disease; cycle sequencing; phenotype; primary immunodeficiency; pyrosequencing; registry

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA SEQUENCE; DNA SPLICING; ENZYME ACTIVITY; FEMALE; GENE; GENE DELETION; GENETIC VARIABILITY; GENOTYPE; GREECE; HUMAN; IMMUNE DEFICIENCY; LYMPHADENOPATHY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NCF1 GENE; NCF2 GENE; NONSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT DISEASE; WESTERN BLOTTING;

GRANULOMATOUS DISEASE, CHRONIC; GREECE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; MALE; MEMBRANE GLYCOPROTEINS; MUTATION; NADPH OXIDASE; REFERRAL AND CONSULTATION; REGISTRIES;

EID: 84888992665     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-014-0100-x     Document Type: Erratum

References (32)

1. Winkelstein JA, Marino MC, Johnston Jr RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79(3):155-69.
2. van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PLoS One. 2009;4(4):e5234. doi: 10.1371/journal.pone.0005234.
3. Leiding JW, Freeman AF, Marciano BE, Anderson VL, Uzel G, Malech HL, et al. Corticosteroid therapy for liver abscess in chronic granulomatous disease. Clin Infect Dis. 2012;54(5):694-700. doi: 10.1093/cid/cir896.
4. Seger RA. Chronic granulomatous disease: recent advances in pathophysiology and treatment. Neth J Med. 2010;68(11):334-40.
5. Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore). 2000;79(3):170-200.
6. Matute JD, Arias AA, Wright NA, Wrobel I, Waterhouse CC, Li XJ, et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood. 2009;114(15):3309-15. doi: 10.1182/blood-2009-07-231498.
7. Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. 2010;45(3):246-65. doi: 10.1016/j.bcmd.2010.07.012.
8. Meerhof LJ, Roos D. Heterogeneity in chronic granulomatous disease detected with an improved nitroblue tetrazolium slide test. J Leukoc Biol. 1986;39(6):699-711.
9. Elbim C, Lizard G. Flow cytometric investigation of neutrophil oxidative burst and apoptosis in physiological and pathological situations. Cytometry A. 2009;75(6):475-81. doi: 10.1002/cyto.a.20726.
10. Roesler J, Hecht M, Freihorst J, Lohmann-Matthes ML, Emmendorffer A. Diagnosis of chronic granulomatous disease and of its mode of inheritance by dihydrorhodamine 123 and flow microcytofluorometry. Eur J Pediatr. 1991;150(3):161-5.
11. Levy R, Rotrosen D, Nagauker O, Leto TL, Malech HL. Induction of the respiratory burst in HL-60 cells. Correlation of function and protein expression. J Immunol. 1990;145(8):2595-601.
12. Nakamura M, Murakami M, Koga T, Tanaka Y, Minakami S. Monoclonal antibody 7D5 raised to cytochrome b558 of human neutrophils: immunocytochemical detection of the antigen in peripheral phagocytes of normal subjects, patients with chronic granulomatous disease, and their carrier mothers. Blood. 1987;69(5):1404-8.
13. Bolscher BG, de Boer M, de Klein A, Weening RS, Roos D. Point mutations in the beta-subunit of cytochrome b558 leading to X-linked chronic granulomatous disease. Blood. 1991;77(11):2482-7.
14. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977;74(12):5463-7.
15. Ronaghi M, Karamohamed S, Pettersson B, Uhlen M, Nyren P. Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem. 1996;242(1):84-9. doi: 10.1006/abio.1996.0432.
16. Hayrapetyan A, Dencher PCD, van Leeuwen K, de Boer M, Roos D. Different unequal cross-over events between NCF1 and its pseudogenes in autosomal p47phox-deficient Chronic Granulomatous Disease. submitted.
17. Hellenic Statistical Association. http://www.statistics.gr/portal/page/ portal/ESYE/BUCKET/General/A1602-SAM01-DT-DC-00-2011-02-F-GR.pdf. Assessed on 2/6/13.
18. Hellenic Statistical Authority Online Database. http://www.statistics.gr/ portal/page/portal/ESYE/PAGE-database. Assessed on 2/6/13.
19. Rae J, Newburger PE, Dinauer MC, Noack D, Hopkins PJ, Kuruto R, et al. X-Linked chronic granulomatous disease: mutations in the CYBB gene encoding the gp91-phox component of respiratory-burst oxidase. Am J Hum Genet. 1998;62(6):1320-31. doi: 10.1086/301874.
20. Roesler J, Curnutte JT, Rae J, Barrett D, Patino P, Chanock SJ, et al. Recombination events between the p47-phox gene and its highly homologous pseudogenes are the main cause of autosomal recessive chronic granulomatous disease. Blood. 2000;95(6):2150-6.
21. Roos D, Kuhns DB, Maddalena A, Bustamante J, Kannengiesser C, de Boer M, et al. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis. 2010;44(4):291-9. doi: 10.1016/j.bcmd.2010.01.009.
22. Costabile M, Quach A, Ferrante A. Molecular approaches in the diagnosis of primary immunodeficiency diseases. Hum Mutat. 2006;27(12):1163-73. doi: 10.1002/humu.20412.
23. Jones LB, McGrogan P, Flood TJ, Gennery AR, Morton L, Thrasher A, et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin Exp Immunol. 2008;152(2):211-8. doi: 10.1111/j.1365-2249.2008.03644.x.
24. Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. Clin Immunol. 2008;126(2):155-64. doi: 10.1016/j.clim.2007.09.008.
25. Martel C, Mollin M, Beaumel S, Brion JP, Coutton C, Satre V, et al. Clinical, functional and genetic analysis of twenty-four patients with chronic granulomatous disease - identification of eight novel mutations in CYBB and NCF2 genes. J Clin Immunol. 2012;32(5):942-58. doi: 10.1007/s10875-012-9698-8.
26. Soler-Palacin P, Margareto C, Llobet P, Asensio O, Hernandez M, Caragol I, et al. Chronic granulomatous disease in pediatric patients: 25 years of experience. Allergol Immunopathol (Madr). 2007;35(3):83-9.
27. Fernandez-Boyanapalli R, McPhillips KA, Frasch SC, Janssen WJ, Dinauer MC, Riches DW, et al. Impaired phagocytosis of apoptotic cells by macrophages in chronic granulomatous disease is reversed by IFN-gamma in a nitric oxide-dependent manner. J Immunol. 2010;185(7):4030-41. doi: 10.4049/jimmunol.1001778.
28. Naderi Beni F, Fattahi F, Mirshafiey A, Ansari M, Mohsenzadegan M, Movahedi M, et al. Increased production of nitric oxide by neutrophils from patients with chronic granulomatous disease on interferon-gamma treatment. Int Immunopharmacol. 2012;12(4):689-93. doi: 10.1016/j.intimp.2012.01.016.
29. Goussetis E, Konialis CP, Peristeri I, Kitra V, Dimopoulou M, Petropoulou T, et al. Successful hematopoietic stem cell transplantation in 2 children with X-linked chronic granulomatous disease from their unaffected HLA-identical siblings selected using preimplantation genetic diagnosis combined with HLA typing. Biol Blood Marrow Transplant. 2010;16(3):344-9. doi: 10.1016/j.bbmt.2009.10.010.
30. Martinez CA, Shah S, Shearer WT, Rosenblatt HM, Paul ME, Chinen J, et al. Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease. J Allergy Clin Immunol. 2012;129(1):176-83. doi: 10.1016/j.jaci.2011.10.005.
31. Kang EM, Malech HL. Gene therapy for chronic granulomatous disease. Methods Enzymol. 2012;507:125-54. doi: 10.1016/B978-0-12-386509-0.00007-7.
32. Aiuti A, Bacchetta R, Seger R, Villa A, Cavazzana-Calvo M. Gene therapy for primary immunodeficiencies: Part 2. Curr Opin Immunol. 2012;24(5):585-91. doi: 10.1016/j.coi.2012.07.012.